Constanze Ulmer-Eilfort
Director/Board Member presso EVOTEC SE
Profilo
Constanze Ulmer-Eilfort is currently the Director at Proxygen Co., an Independent Member-Supervisory Board at Affimed NV, a Member-Supervisory Board at Evotec SE, and a Partner at Peters, Schönberger & Partner GbR.
Previously, he worked as a Partner at Baker Mckenzie LLP from 1998 to 2021.
Dr. Ulmer-Eilfort holds a graduate degree from the University of Pennsylvania, a doctorate degree from Freie Universität Berlin, and a graduate degree from Ludwig-Maximilians-Universität München.
Posizioni attive di Constanze Ulmer-Eilfort
Società | Posizione | Inizio |
---|---|---|
EVOTEC SE | Director/Board Member | 01/06/2021 |
AFFIMED N.V. | Director/Board Member | 21/06/2023 |
Peters, Schönberger & Partner GbR
Peters, Schönberger & Partner GbR Miscellaneous Commercial ServicesCommercial Services Peters, Schönberger & Partner is a Munich-based law firm that provides legal advice and data protection services. The German company specializes in auditing and creating annual financial statements, representing clients in state courts and arbitration, and providing practical and interdisciplinary support to foundations, non-profit organizations, and other charitable institutions. The firm also offers investment office services for large assets, as well as neutral assessment, arbitration, and consulting services for businesses. Peters, Schönberger & Partner is a competent partner for medium-sized and international companies, private equity firms, and NPOs. The company also provides advice and support on tax compliance management and GoBD. | Corporate Officer/Principal | 01/01/2022 |
Proxygen Co.
Proxygen Co. Investment ManagersFinance Proxygen Co. is an American biotech company focused on the discovery and development of molecular glue degraders against targets of unmet medical need across various indications. Proxygen's headquarters and laboratory operations are based in an undisclosed location, and the private company employs talent both locally and remotely all over. The company maintains strategic partnerships with Merck & Co, Boehringer Ingelheim, and Merck KGaA to co-create synergies along the drug development pipeline. | Director/Board Member | 01/01/2022 |
Precedenti posizioni note di Constanze Ulmer-Eilfort
Società | Posizione | Fine |
---|---|---|
Baker Mckenzie LLP | Corporate Officer/Principal | 01/01/2021 |
Formazione di Constanze Ulmer-Eilfort
University of Pennsylvania | Graduate Degree |
Freie Universität Berlin | Doctorate Degree |
Ludwig-Maximilians-Universität München | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
AFFIMED N.V. | Health Technology |
EVOTEC SE | Health Technology |
Aziende private | 3 |
---|---|
Peters, Schönberger & Partner GbR
Peters, Schönberger & Partner GbR Miscellaneous Commercial ServicesCommercial Services Peters, Schönberger & Partner is a Munich-based law firm that provides legal advice and data protection services. The German company specializes in auditing and creating annual financial statements, representing clients in state courts and arbitration, and providing practical and interdisciplinary support to foundations, non-profit organizations, and other charitable institutions. The firm also offers investment office services for large assets, as well as neutral assessment, arbitration, and consulting services for businesses. Peters, Schönberger & Partner is a competent partner for medium-sized and international companies, private equity firms, and NPOs. The company also provides advice and support on tax compliance management and GoBD. | Commercial Services |
Proxygen Co.
Proxygen Co. Investment ManagersFinance Proxygen Co. is an American biotech company focused on the discovery and development of molecular glue degraders against targets of unmet medical need across various indications. Proxygen's headquarters and laboratory operations are based in an undisclosed location, and the private company employs talent both locally and remotely all over. The company maintains strategic partnerships with Merck & Co, Boehringer Ingelheim, and Merck KGaA to co-create synergies along the drug development pipeline. | Finance |
Baker Mckenzie LLP |
- Borsa valori
- Insiders
- Constanze Ulmer-Eilfort